Labvax 3(22)-23 - LabyRx Immuno-Oncology
Keytruda (pembrolizumab) - Merck (MSD)
https://www.abstractsonline.com/pp8/#!/20273/presentation/10099
 
Tianhong Li1; Ruqiang Liang1; Shuai Chen1; Dennis Montoya1; Siqi Long1; Kit Wah Tam1; Kylie Blaisdell1; Leslie Garcia1; Laura Molnar-McNulty1; Colleen A. Pineda1; Michael Babich2; Primo N. Lara1
 
Mar 26, 2025
 
Next